AstraZeneca

www.astrazeneca.com

15 Stanhope Gate
London
W1K 1LN
United Kingdom

+44 20 7304 5000

Activities

Drug Delivery | Research & Development | Pharmaceutical

Related Companies

Related Content

Therapeutic: capivasertib as an anticancer agent
Therapeutic: capivasertib as an anticancer agent
AstraZeneca meets primary endpoint in MANDARA Phase III trial
AstraZeneca meets primary endpoint in MANDARA Phase III trial
AstraZeneca's Forxiga approved in China to reduce cardiovascular death
AstraZeneca's Forxiga approved in China to reduce cardiovascular death
AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study
AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study
AstraZeneca's anti-diabetes drug approved in China
AstraZeneca's anti-diabetes drug approved in China
Quell signs licence with AstraZeneca for Treg cell therapies
Quell signs licence with AstraZeneca for Treg cell therapies
Therapeutic: eplontersen for ATTRv-PN
Therapeutic: eplontersen for ATTRv-PN
AstraZeneca’s DELIVER Phase III trial reveals heart failure results
AstraZeneca’s DELIVER Phase III trial reveals heart failure results
Revvity announces license agreement for base editing tech with AstraZeneca
Revvity announces license agreement for base editing tech with AstraZeneca
SeraNovo and AstraZeneca to collaborate on research projects
SeraNovo and AstraZeneca to collaborate on research projects
Farxiga extended in the US to reduce risk of cardiovascular death
Farxiga extended in the US to reduce risk of cardiovascular death
Study reveals growing burden of heart failure on healthcare
Study reveals growing burden of heart failure on healthcare
AstraZeneca's drug approved in EU for treatment of symptomatic heart failure
AstraZeneca's drug approved in EU for treatment of symptomatic heart failure
Tickets now on sale for 2023 Manufacturing Chemist Live
Tickets now on sale for 2023 Manufacturing Chemist Live
Manufacturing Chemist LIVE 2023: Become an official sponsor
Manufacturing Chemist LIVE 2023: Become an official sponsor